How much does Ramucirumab cost?

Ramucirumab is indicated for the treatment of advanced or metastatic gastric or gastroesophageal junction adenocarcinoma as a single agent or in combination with paclitaxel in patients who have progressed after prior fluoropyrimidine- or platinum-containing chemotherapy. CombinationFOLFIRI (leucovorin, fluorouracil, and irinotecan) is indicated for the treatment of patients with metastatic colorectal cancer who have progressed after treatment with bevacizumab, oxaliplatin, and fluoropyrimidine.

Ramosumab will be used in combination with erlotinib and is suitable for the first-line treatment of metastatic non-small cell lung cancer with epidermal growth factor exon 19 deletion or exon 21 (L858R) point mutation. It is also indicated in combination with docetaxel for the treatment of patients with metastatic non-small cell lung cancer who have progressed after prior platinum-based chemotherapy. Patients with EGFR or ALK genomic abnormalities should also experience disease progression after receiving FDA-approved treatments. Finallyramucizumabis suitable for the treatment of hepatocellular carcinoma patients with alpha-fetoprotein levels≥400 ng/mL and who have been previously treated with sorafenib.

Ramosizumab is usually an injection preparation. The original drug has been on the market in China, but it has been on the market for a short time and has not been included in the medical insurance. The price of 100mg/10mL per box may be around RMB 5,000, and the price of 500mg/50mL per box may be around RMB 17,000. The price of the original Hong Kong version of 100mg/10mL may be around RMB 8,400 per box, and the price of 500mg/50mL per box may be around RMB 28,000 (the price may fluctuate due to exchange rates), and their pharmaceutical ingredients are basically the same. Currently, there are no generic drugs produced and marketed overseas. For specific prices and drug information, please consult Yaode’s medical consultant.